PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3384770

Epidemic methicillin-resistant Staphylococcus aureus.

B D Cookson·I Phillips
View original source ↗Export metadata ↓

Abstract

We contrast the experiences, in our Health Authority in South-East London, with the particular epidemic methicillin-resistant Staphylococcus aureus (the EMRSA) strain that has recently spread widely around London and South-East England, and with the other MRSA (OMRSA) strains encountered there. Our isolates of the EMRSA were identical by chromosomal restriction enzyme analysis, and the chromosomal and plasmid phenotypes were similar to those described in North London and Eastern Australia. Experimental phage-typing distinguished them from OMRSA encountered in 1984 to 1986. Between 1984 and 1985, the EMRSA caused increased infection and patient colonization compared to the years 1969 to 1983. A change in infection control procedures was usually required to control the EMRSA and in 1986 isolates had returned to their pre-1984 levels. Between 1984 and 1986 OMRSA were still encountered, but did not spread or require changes in infection control procedures. The distribution of other resistant isolates was examined; c 94% of neomycin-resistant isolates were in-patients or clinic patients. Forty-five different phage-type/antibiogram patterns were found in 88 isolates from 66 patients between 1982 and 1985, and patient clusters were uncommon. The ability of the EMRSA to spread is discussed and is probably not purely organism related. Our experience supports the contention that some MRSA are truly epidemic, whilst others do not behave in this manner.

Explore related subjects

HumansMethicillinPenicillin ResistanceStaphylococcus aureusTime FactorsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B D Cookson, I Phillips. 1988. Epidemic methicillin-resistant Staphylococcus aureus.. https://doi.org/10.1093/jac%2F21.suppl_c.57

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗